Drug Shortage Report for ERFA-AMIKACIN

Last updated on 2021-12-08 History
Report ID 139653
Drug Identification Number 02489147
Brand name ERFA-AMIKACIN
Common or Proper name ERFA-AMIKACIN
Company Name ERFA CANADA 2012 INC
Market Status MARKETED
Active Ingredient(s) AMIKACIN
Strength(s) 250MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 2ML
ATC code J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-06-01
Actual start date 2021-05-19
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2021-12-08
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 8250 BLVD DECARIE, SUITE 110
MONTREAL, QUEBEC
CANADA H4P 2P5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-12-08 French Compare
v5 2021-12-08 English Compare
v4 2021-12-08 English Compare
v3 2021-05-20 English Compare
v2 2021-05-19 French Compare
v1 2021-05-19 English Compare

Showing 1 to 6 of 6